Terms: = Gastric cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Prognosis
23 results:
1. The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer.
Li XF; Zhang XJ; Hao FR; Dong XT; Xu GD; Zhang YX
J Int Med Res; 2024 Mar; 52(3):3000605241234558. PubMed ID: 38518198
[TBL] [Abstract] [Full Text] [Related]
2. High
Dazhi W; Zheng J; Chunling R
Future Med Chem; 2020 Dec; 12(24):2209-2224. PubMed ID: 33191789
[No Abstract] [Full Text] [Related]
3. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
Xiao M; Lin J; Xiao T; Lin Y; Ye Y
Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
[TBL] [Abstract] [Full Text] [Related]
4. Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.
Berardi R; Torniai M; Partelli S; Rubini C; Pagliaretta S; Savini A; Polenta V; Santoni M; Giampieri R; Onorati S; Barucca F; Murrone A; Bianchi F; Falconi M
PLoS One; 2018; 13(5):e0197035. PubMed ID: 29787601
[TBL] [Abstract] [Full Text] [Related]
5. VEGFR-2 as a novel predictor of survival in gastric cancer: A systematic review and meta-analysis
.
Li T; Yu J; Luo X; Ren W; Zhang Y; Cao B
Pathol Res Pract; 2018 Apr; 214(4):560-564. PubMed ID: 29572120
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis.
Ge H; Yan Y; Guo L; He X; Yang X
Clin Chim Acta; 2017 Nov; 474():114-119. PubMed ID: 28939099
[TBL] [Abstract] [Full Text] [Related]
7. Galectin-9 suppresses the proliferation of gastric cancer cells in vitro.
Takano J; Morishita A; Fujihara S; Iwama H; Kokado F; Fujikawa K; Fujita K; Chiyo T; Tadokoro T; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Mori H; Niki T; Hirashima M; Masaki T
Oncol Rep; 2016 Feb; 35(2):851-60. PubMed ID: 26717877
[TBL] [Abstract] [Full Text] [Related]
8. Contactin 1: A potential therapeutic target and biomarker in gastric cancer.
Chen DH; Yu JW; Jiang BJ
World J Gastroenterol; 2015 Sep; 21(33):9707-16. PubMed ID: 26361417
[TBL] [Abstract] [Full Text] [Related]
9. Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients.
Scartozzi M; Giampieri R; Loretelli C; Bittoni A; Mandolesi A; Faloppi L; Bianconi M; Del Prete M; Andrikou K; Bearzi I; Cascinu S
Pharmacogenomics; 2013 Dec; 14(16):1991-8. PubMed ID: 24090479
[TBL] [Abstract] [Full Text] [Related]
10. Serum VEGF and VEGF-C values before surgery and after postoperative treatment in gastric cancer.
Villarejo-Campos P; Padilla-Valverde D; Martin RM; Menéndez-Sánchez P; Cubo-Cintas T; Bondia-Navarro JA; Fernández JM
Clin Transl Oncol; 2013 Apr; 15(4):265-70. PubMed ID: 22855190
[TBL] [Abstract] [Full Text] [Related]
11. A randomized trial of somatostatin to regulate the VEGFs/VEGFRs in patients with gastric cancer.
Zhao B; Yang P; Yang J; Cai D
Hepatogastroenterology; 2011; 58(109):1425-30. PubMed ID: 21937420
[TBL] [Abstract] [Full Text] [Related]
12. The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma.
Han FH; Li HM; Zheng DH; He YL; Zhan WH
Eur J Surg Oncol; 2010 Dec; 36(12):1172-9. PubMed ID: 20888167
[TBL] [Abstract] [Full Text] [Related]
13. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
Wang XL; Fang JP; Tang RY; Chen XM
BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
[TBL] [Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor-D is correlated with hepatic metastasis from gastric cancer after radical gastrectomy.
Deng J; Liang H; Sun D; Pan Y; Wang B; Guo Y
Surgery; 2009 Nov; 146(5):896-905. PubMed ID: 19744460
[TBL] [Abstract] [Full Text] [Related]
15. Molecular characterization and significance for prognosis of free gastric cancer cells in the peritoneal cavity.
Li C; Ma Y; Xue Y; Zhang H; Wei Y
Hepatogastroenterology; 2009; 56(91-92):891-8. PubMed ID: 19621724
[TBL] [Abstract] [Full Text] [Related]
16. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract] [Full Text] [Related]
17. Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer.
Da MX; Wu XT; Wang J; Guo TK; Zhao ZG; Luo T; Zhang MM; Qian K
Arch Med Res; 2008 Jan; 39(1):92-9. PubMed ID: 18068001
[TBL] [Abstract] [Full Text] [Related]
18. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor.
Yuanming L; Feng G; Lei T; Ying W
Arch Med Res; 2007 Jan; 38(1):106-12. PubMed ID: 17174733
[TBL] [Abstract] [Full Text] [Related]
19. [The expression of VEGF-C, VEGFR-3 and its predictive value on lymph node metastasis and prognosis of gastric cancer].
Han FH; Zhan WH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1058-61. PubMed ID: 17074247
[TBL] [Abstract] [Full Text] [Related]
20. [Study on the correlation between the expressions of nm23H1 mRNA, VEGF-C mRNA and lymphatic metastases, survival rate with gastric cancer].
Ding GF; Li JC; Li CS; Xu YF; Sun Y; Chen XR
Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Feb; 39(1):46-54. PubMed ID: 16944571
[TBL] [Abstract] [Full Text] [Related]
[Next]
